A study in the journal AIDS found that protease inhibitor-based therapy was associated with an increased likelihood of the development of diabetes in some women with a genetic risk for the condition. The study highlights the need for individualized HIV/AIDS regimens based on genetic risk factors, researchers said.

Full Story:

Related Summaries